Z. Naturforsch. 2017; aop
Corrigendum Ling-Ling Pan, Wen-Jun Wu, Gao-Feng Zheng, Xiao-Yan Han, Jing-Song He and Zhen Cai*
Corrigendum to: Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway https://doi.org/10.1515/znc-2017-0171
Corrigendum to: Ling-Ling Pan, Wen-Jun Wu, Gao-Feng Zheng, Xiao-Yan Han, Jing-Song He and Zhen Cai. Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway. Z. Naturforsch. 72c, aop. (DOI: 10.1515/znc-2016-0210): For the reader’s convenience, the corrected text appears below. 1. Page 1: Abstract: chronic lymphoblastic leukemia (CLL) should be corrected as chronic myeloid leukemia 2. Page 1: Keywords: chronic lymphoblastic leukemia should be corrected as chronic myeloid leukemia 3. Page 1: The first paragraph of the Introduction should be replaced by following description: Chronic myeloid leukemia (CML), an acquired malignant myeloproliferative disorder of hematopoietic stem cells, is one of the three most common forms of leukemia. Leukemia accounted for some 352,000 new cases (2.5% of all new cancer cases) and for 265,000 deaths (3.2% of all deaths) in 2012 worldwide [1, 2]. Currently, an effective therapy for CML is still lacking. Thus, it is critical to develop a novel therapeutic agent that is more specific to CML [3, 4].
4. Page 2: 2.1 Cell culture: CLL should be corrected as CML 5. Page 5: Results subtitle – 3.5 CLL should be corrected as CML 6. Discussion part: There are four “CLL” in this part, and all CLL should be corrected as CML 7. Reference part: From the first reference to the fourth reference should be replaced by following: –– Zhang JY, Lin MT, Tung HY, Tang SL, Yi T, Zhang YZ, et al. Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway. Am J Cancer Res 2016;6:819–26. –– Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. –– Tabarestani S, Movafagh A. New developments in chronic myeloid leukemia: implications for therapy. Iran J Cancer Prev 2016;9:e3961. –– Mughal TI, Radich JP, Deininger MW, Apperley JF, Hughes TP, Harrison CJ, et al. Chronic myeloid leukemia: reminiscences and dreams. Haematologica 2016;101:541–58.
*Corresponding author: Zhen Cai, The Bone Marrow Transplantation, Center and Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou 310003, China, E-mail: [email protected] Ling-Ling Pan: The Bone Marrow Transplantation Center and Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou 310003, China; and Blood Center of Zhejiang Province, Hangzhou 310006, China Wen-Jun Wu, Gao-Feng Zheng, Xiao-Yan Han and Jing-Song He: The Bone Marrow Transplantation Center and Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou 310003, China
Brought to you by | University of Gothenburg Authenticated Download Date | 10/11/17 3:10 PM
Corrigendum Ling-Ling Pan, Wen-Jun Wu, Gao-Feng Zheng, Xiao-Yan Han, Jing-Song He and Zhen Cai*
Corrigendum to: Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway https://doi.org/10.1515/znc-2017-0171
Corrigendum to: Ling-Ling Pan, Wen-Jun Wu, Gao-Feng Zheng, Xiao-Yan Han, Jing-Song He and Zhen Cai. Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway. Z. Naturforsch. 72c, aop. (DOI: 10.1515/znc-2016-0210): For the reader’s convenience, the corrected text appears below. 1. Page 1: Abstract: chronic lymphoblastic leukemia (CLL) should be corrected as chronic myeloid leukemia 2. Page 1: Keywords: chronic lymphoblastic leukemia should be corrected as chronic myeloid leukemia 3. Page 1: The first paragraph of the Introduction should be replaced by following description: Chronic myeloid leukemia (CML), an acquired malignant myeloproliferative disorder of hematopoietic stem cells, is one of the three most common forms of leukemia. Leukemia accounted for some 352,000 new cases (2.5% of all new cancer cases) and for 265,000 deaths (3.2% of all deaths) in 2012 worldwide [1, 2]. Currently, an effective therapy for CML is still lacking. Thus, it is critical to develop a novel therapeutic agent that is more specific to CML [3, 4].
4. Page 2: 2.1 Cell culture: CLL should be corrected as CML 5. Page 5: Results subtitle – 3.5 CLL should be corrected as CML 6. Discussion part: There are four “CLL” in this part, and all CLL should be corrected as CML 7. Reference part: From the first reference to the fourth reference should be replaced by following: –– Zhang JY, Lin MT, Tung HY, Tang SL, Yi T, Zhang YZ, et al. Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway. Am J Cancer Res 2016;6:819–26. –– Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. –– Tabarestani S, Movafagh A. New developments in chronic myeloid leukemia: implications for therapy. Iran J Cancer Prev 2016;9:e3961. –– Mughal TI, Radich JP, Deininger MW, Apperley JF, Hughes TP, Harrison CJ, et al. Chronic myeloid leukemia: reminiscences and dreams. Haematologica 2016;101:541–58.
*Corresponding author: Zhen Cai, The Bone Marrow Transplantation, Center and Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou 310003, China, E-mail: [email protected] Ling-Ling Pan: The Bone Marrow Transplantation Center and Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou 310003, China; and Blood Center of Zhejiang Province, Hangzhou 310006, China Wen-Jun Wu, Gao-Feng Zheng, Xiao-Yan Han and Jing-Song He: The Bone Marrow Transplantation Center and Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou 310003, China
Brought to you by | University of Gothenburg Authenticated Download Date | 10/11/17 3:10 PM
